within Pharmacolibrary.Drugs.ATC.B;

model B02AA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 126 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,
    adminCount     = 1,
    Vd             = 0.00023,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Aminocaproic acid is a synthetic derivative of the amino acid lysine and acts as an antifibrinolytic agent by inhibiting plasminogen activation, thereby reducing fibrinolysis and bleeding. It is primarily used to control excessive bleeding in conditions such as fibrinolytic states (e.g., after surgery, trauma, or bleeding disorders). Aminocaproic acid is approved and in clinical use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult healthy volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Eaton, MP, et al., &amp; Anderson, B (2015). Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass. <i>Anesthesiology</i> 122(5) 1002–1009. DOI:<a href=&quot;https://doi.org/10.1097/ALN.0000000000000616&quot;>10.1097/ALN.0000000000000616</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25723765/&quot;>https://pubmed.ncbi.nlm.nih.gov/25723765</a></p></li><li><p>Ross, J, et al., &amp; Sweeney, RW (2007). Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses. <i>American journal of veterinary research</i> 68(9) 1016–1021. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.68.9.1016&quot;>10.2460/ajvr.68.9.1016</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17764418/&quot;>https://pubmed.ncbi.nlm.nih.gov/17764418</a></p></li><li><p>Lee, U, et al., &amp; Lee, MG (2012). ε-Acetamidocaproic acid pharmacokinetics in rats with gastric ulcer or small bowel inflammation. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 42(3) 310–315. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2011.619014&quot;>10.3109/00498254.2011.619014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21992030/&quot;>https://pubmed.ncbi.nlm.nih.gov/21992030</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B02AA01;
